Skip to content
10-Q

Quarterly Report

Boundless Bio, Inc. BOLD

0001193125-26-213321

← back to feed
Filed
May 8, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2026 · May 5, 2026 22.46M sh
Shares Diluted Q1 2026 · Mar 31, 2026 22.41M sh
Shares Diluted Q1 2026 · Mar 31, 2025 22.3M sh
Capex Q1 2026 · Mar 31, 2026 $8K
Capex Q1 2026 · Mar 31, 2025 $59K
Operating Cash Flow Q1 2026 · Mar 31, 2026 −$14.97M
Operating Cash Flow Q1 2026 · Mar 31, 2025 −$14.53M
Short Term Investments Q1 2026 · Mar 31, 2026 $75.36M
Short Term Investments Q1 2026 · Dec 31, 2025 $89.71M
Cash And Equivalents Q1 2026 · Mar 31, 2026 $17.48M
Cash And Equivalents Q1 2026 · Dec 31, 2025 $17.87M
Cash And Equivalents Q1 2026 · Mar 31, 2025 $15.12M
Stockholders Equity Q1 2026 · Mar 31, 2026 $86.38M
Stockholders Equity Q1 2026 · Dec 31, 2025 $98.65M
Current Liabilities Q1 2026 · Mar 31, 2026 $9.58M
Current Liabilities Q1 2026 · Dec 31, 2025 $12.54M
Total Liabilities Q1 2026 · Mar 31, 2026 $54.59M
Total Liabilities Q1 2026 · Dec 31, 2025 $58.41M
Current Assets Q1 2026 · Mar 31, 2026 $94.62M
Current Assets Q1 2026 · Dec 31, 2025 $109.61M
Total Assets Q1 2026 · Mar 31, 2026 $140.97M
Total Assets Q1 2026 · Dec 31, 2025 $157.06M
Eps Diluted Q1 2026 · Mar 31, 2026 −$0.60
Eps Diluted Q1 2026 · Mar 31, 2025 −$0.71
Eps Basic Q1 2026 · Mar 31, 2026 −$0.60
Eps Basic Q1 2026 · Mar 31, 2025 −$0.71
Sga Expense Q1 2026 · Mar 31, 2026 $4.74M
Sga Expense Q1 2026 · Mar 31, 2025 $5.2M
Rd Expense Q1 2026 · Mar 31, 2026 $9.73M
Rd Expense Q1 2026 · Mar 31, 2025 $12.14M
Net Income Q1 2026 · Mar 31, 2026 −$13.56M
Net Income Q1 2026 · Mar 31, 2025 −$15.76M
Operating Income Q1 2026 · Mar 31, 2026 −$14.48M
Operating Income Q1 2026 · Mar 31, 2025 −$17.34M